New Drug Review: Trodelvy

Inbox

x

MPR First Look <editor@email.empr.com> Unsubscribe

Wed, May 20, 7:09 PM (1 day ago)

to me

If you are having trouble viewing this email, click here.

NEW DRUG PRODUCT: TRODELVY FEATURED Find out more about Trodelvy including dosing and important safety information with our slideshow, complete drug monograph, and downloadable PDF. DRUGS IN THE PIPELINE NIH Trial Evaluating Remdesivir Plus Baricitinib for COVID-19 Initiated FDA Greenlights Study to Evaluate Opaganib in Patients With Moderate to Severe COVID-19 Microbiome-Based Therapy Looks Promising for Recurrent C. Difficile Infection Positive Results With Mavacamten for Obstructive Hypertrophic Cardiomyopathy Omecamtiv Mecarbil Gets Fast Track Status for Heart Failure The right dose of information. eMPR.com CME/CE Spotlight Dispelling the Myths of Influenza Management AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME